Marketing and Retailing

Regulatory tracker: current global regulation of CBD December

15th December 2021 - Regulatory trackers |

CBD-Intel’s newly upgraded global regulatory tracker, updated every month, now offers a deeper analysis of each regulatory area.

Use the tabs at the top of the map to select a specific regulatory field and click on an individual country to bring up much more detail in the panel below, including links to legislation and CBD-Intel’s coverage of that market.

The key below the map indicates the level of regulation for the selected country and regulatory field based on our in-house analysis.

UK CBD insights dashboard

9th December 2021 - Market trackers |

This interactive dashboard provides a detailed look at the current CBD market in the UK, including information about product formats, pricing and brands

Could CBD/hemp vaping equipment be exempt from the incoming rule prohibiting the mailing of e-cigarette and vaporiser-related products through the US Postal Service (USPS)?

7th May 2021 - Blog |

Recent consultation guidance does suggest that the USPS is considering broadly exempting hemp and CBD services from the incoming rule. The guidance states: “For hemp-based products containing CBD with a THC concentration not exceeding 0.3 percent, mailers must retain, and prepare to make available upon request, records establishing compliance with all applicable federal, state, and […]

What is the state of science behind minor cannabinoids really like?

29th April 2021 - Blog |

Minor cannabinoids are gaining increasing interest – pushed by both slowly growing consumer awareness and companies looking to develop further revenue streams from under-utilised products. A number of claims have been made about the properties of various minor cannabinoids – some skirting dangerously close to the line of what is currently permitted and some going […]

Is delta-8 THC really the next big thing?

14th April 2021 - Blog |

From a consumer/market perspective, it certainly looks like delta-8 THC is the most promising minor cannabinoid. It has quickly overtaken others such as CBG and CBN in terms of general awareness and – anecdotally – in terms of interest from companies and consumers alike. The appeal appears to be that it acts as a “lighter” version of delta-9 […]